Decorin, erythroblastic leukaemia viral oncogene homologue B4 and signal transducer and activator of transcription 3 regulation of semaphorin 3A in central nervous system scar tissue

Brain

Volumn 134, Issue 4, 2011, Pages 1140-1155

  Minor, Kenneth H ^a   Bournat, Juan C ^b   Toscano, Nicole ^c   Giger, Roman J ^c,d   Davies, Stephen J A ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

decorin; ErbB4; scar; semaphorin; STAT3

Indexed keywords

CHONDROITIN SULFATE; DECORIN; MESSENGER RNA; SEMAPHORIN 3A; STAT3 PROTEIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN CORTEX LESION; BRAIN INJURY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DNA SYNTHESIS; ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOGUE B4; FEMALE; FIBROBLAST; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VITRO STUDY; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SCAR; SEQUENCE HOMOLOGY; SPINAL CORD; VIRUS ONCOGENE;

ANIMALS; CELLS, CULTURED; CEREBRAL CORTEX; CICATRIX; DECORIN; FEMALE; FIBROBLASTS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NERVE REGENERATION; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEMAPHORIN-3A; STAT3 TRANSCRIPTION FACTOR;

EID: 79953657581     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awq304     Document Type: Article

References (101)

1. Acarin L, Gonzalez B, Castellano B. STAT3 and NFkappaB activation precedes glial reactivity in the excitotoxically injured young cortex but not in the corresponding distal thalamic nuclei. J Neuropathol Exp Neurol 2000; 59: 151-63. (Pubitemid 30106471)
2. Arakawa T, Masaki T, Hirai T, Doi S, Kuratsune M, Arihiro K, et al. Activation of signal transducer and activator of transcription 3 correlates with cell proliferation and renal injury in human glomeruloneph-ritis. Nephrol Dial Transplant 2008; 23: 3418-26.
3. Bagnard D, Lohrum M, Uziel D, Puschel AW, Bolz J. Semaphorins act as attractive and repulsive guidance signals during the development of cortical projections. Development 1998; 125: 5043-53. (Pubitemid 29026785)
4. Beck H, Acker T, Puschel AW, Fujisawa H, Carmeliet P, Plate KH. Cell type-specific expression of neuropilins in an MCA-occlusion model in mice suggests a potential role in post-ischemic brain remodeling. J Neuropathol Exp Neurol 2002; 61: 339-50. (Pubitemid 34266785)
5. Berthier CC, Zhang H, Schin M, Henger A, Nelson RG, Yee B, et al. Enhanced expression of Janus kinase-signal transducer and activator of transcription pathway members in human diabetic nephropathy. Diabetes 2009; 58: 469-77.
6. Blaskovich MA, Sun J, Cantor A, Turkson J, Jove R, Sebti SM. Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Cancer Res 2003; 63: 1270-9. (Pubitemid 36348705)
7. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, et al. Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 1992; 360: 361-4. (Pubitemid 23000677)
8. Bouzioukh F, Daoudal G, Falk J, Debanne D, Rougon G, Castellani V. Semaphorin3A regulates synaptic function of differentiated hippocam-pal neurons. Eur J Neurosci 2006; 23: 2247-54. (Pubitemid 43742857)
9. Brandan E, Retamal C, Cabello-Verrugio C, Marzolo MP. The low density lipoprotein receptor-related protein functions as an endocytic receptor for decorin. J Biol Chem 2006; 281: 31562-71. (Pubitemid 46041422)
10. Cabello-Verrugio C, Brandan E. A novel modulatory mechanism of transforming growth factor-beta signaling through decorin and LRP-1. J Biol Chem 2007; 282: 18842-50. (Pubitemid 47100183)
11. Carpenter G. ErbB-4: mechanism of action and biology. Exp Cell Res 2003a; 284: 66-77. (Pubitemid 36331966)
12. Carpenter G. Nuclear localization and possible functions of receptor tyro-sine kinases. Curr Opin Cell Biol 2003b; 15: 143-8. (Pubitemid 36332188)
13. Csordas G, Santra M, Reed CC, Eichstetter I, McQuillan DJ, Gross D, et al. Sustained down-regulation of the epidermal growth factor receptor by decorin. A mechanism for controlling tumor growth in vivo. J Biol Chem 2000; 275: 32879-87.
14. David M, Chen HE, Goelz S, Larner AC, Neel BG. Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol Cell Biol 1995; 15: 7050-8. (Pubitemid 3004334)
15. Davies JE, Tang X, Denning JW, Archibald SJ, Davies SJ. Decorin suppresses neurocan, brevican, phosphacan and NG2 expression and promotes axon growth across adult rat spinal cord injuries. Eur J Neurosci 2004; 19: 1226-42. (Pubitemid 38387200)
16. Davies SJ, Fitch MT, Memberg SP, Hall AK, Raisman G, Silver J. Regeneration of adult axons in white matter tracts of the central nervous system. Nature 1997; 390: 680-3. (Pubitemid 28016354)
17. Davies SJ, Goucher DR, Doller C, Silver J. Robust regeneration of adult sensory axons in degenerating white matter of the adult rat spinal cord. J Neurosci 1999; 19: 5810-22. (Pubitemid 29327918)
18. De WF, Oudega M, Lankhorst AJ, Hamers FP, Blits B, Ruitenberg MJ, et al. Injury-induced class 3 semaphorin expression in the rat spinal cord. Exp Neurol 2002; 175: 61-75. (Pubitemid 34507910)
19. De WF, Vo T, Stam FJ, Wisman LA, Bar PR, Niclou SP, et al. The expression of the chemorepellent Semaphorin 3A is selectively induced in terminal Schwann cells of a subset of neuromuscular synapses that display limited anatomical plasticity and enhanced vulnerability in motor neuron disease. Mol Cell Neurosci 2006; 32: 102-17. (Pubitemid 43868100)
20. Dent EW, Barnes AM, Tang F, Kalil K. Netrin-1 and semaphorin 3A promote or inhibit cortical axon branching, respectively, by reorganization of the cytoskeleton. J Neurosci 2004; 24: 3002-12. (Pubitemid 38405747)
21. Eastwood SL. The synaptic pathology of schizophrenia: is aberrant neu-rodevelopment and plasticity to blame? Int Rev Neurobiol 2004; 59: 47-72. (Pubitemid 39752411)
22. Eastwood SL, Law AJ, Everall IP, Harrison PJ. The axonal chemorepellant semaphorin 3A is increased in the cerebellum in schizophrenia and may contribute to its synaptic pathology. Mol Psychiatry 2003; 8: 148-55. (Pubitemid 36315223)
23. Feiner L, Koppel AM, Kobayashi H, Raper JA. Secreted chick semaphor-ins bind recombinant neuropilin with similar affinities but bind different subsets of neurons in situ. Neuron 1997; 19: 539-45. (Pubitemid 27430743)
24. Fenstermaker V, Chen Y, Ghosh A, Yuste R. Regulation of dendritic length and branching by semaphorin 3A. J Neurobiol 2004; 58: 403-12. (Pubitemid 38199127)
25. Fujita H, Zhang B, Sato K, Tanaka J, Sakanaka M. Expressions of neuropilin-1, neuropilin-2 and semaphorin 3A mRNA in the rat brain after middle cerebral artery occlusion. Brain Res 2001; 914: 1-14. (Pubitemid 32905426)
26. Fukushima K, Badlani N, Usas A, Riano F, Fu F, Huard J. The use of an antifibrosis agent to improve muscle recovery after laceration. Am J Sports Med 2001; 29: 394-402. (Pubitemid 32661352)
27. Giger RJ, Pasterkamp RJ, Heijnen S, Holtmaat AJ, Verhaagen J. Anatomical distribution of the chemorepellent semaphorin III/ collapsin-1 in the adult rat and human brain: predominant expression in structures of the olfactory-hippocampal pathway and the motor system. J Neurosci Res 1998a; 52: 27-42. (Pubitemid 28158823)
28. Giger RJ, Urquhart ER, Gillespie SK, Levengood DV, Ginty DD, Kolodkin AL. Neuropilin-2 is a receptor for semaphorin IV: insight into the structural basis of receptor function and specificity. Neuron 1998b; 21: 1079-92. (Pubitemid 29018077)
29. Giger RJ, Wolfer DP, De Wit GM, Verhaagen J. Anatomy of rat sema-phorin III/collapsin-1 mRNA expression and relationship to developing nerve tracts during neuroembryogenesis. J Comp Neurol 1996; 375: 378-92. (Pubitemid 26374779)
30. Goldoni S, Humphries A, Nystrom A, Sattar S, Owens RT, McQuillan DJ, et al. Decorin is a novel antagonistic ligand of the Met receptor. J Cell Biol 2009; 185: 743-54.
31. Good PF, Alapat D, Hsu A, Chu C, Perl D, Wen X, et al. A role for semaphorin 3A signaling in the degeneration of hippocampal neurons during Alzheimer's disease. J Neurochem 2004; 91: 716-36. (Pubitemid 39431165)
32. Grisanti S, Szurman P, Warga M, Kaczmarek R, Ziemssen F, Tatar O, et al. Decorin modulates wound healing in experimental glaucoma filtration surgery: a pilot study. Invest Ophthalmol Vis Sci 2005; 46: 191-6. (Pubitemid 40041197)
33. Gu C, Yoshida Y, Livet J, Reimert DV, Mann F, Merte J, et al. Semaphorin 3E and plexin-D1 control vascular pattern independently of neuropilins. Science 2005; 307: 265-8. (Pubitemid 40116243)
34. Herrmann JE, Imura T, Song B, Qi J, Ao Y, Nguyen TK, et al. STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J Neurosci 2008; 28: 7231-43.
35. Hocking AM, Shinomura T, McQuillan DJ. Leucine-rich repeat glycopro-teins of the extracellular matrix. Matrix Biol 1998; 17: 1-19. (Pubitemid 28206020)
36. Hou ST, Keklikian A, Slinn J, O'Hare M, Jiang SX, Aylsworth A. Sustained up-regulation of semaphorin 3A, Neuropilin1, and doublecortin expression in ischemic mouse brain during long-term recovery. Biochem Biophys Res Commun 2008; 367: 109-15.
37. Huijun W, Long C, Zhigang Z, Feng J, Muyi G. Ex vivo transfer of the decorin gene into rat glomerulus via a mesangial cell vector suppressed extracellular matrix accumulation in experimental glomerulonephritis. Exp Mol Pathol 2005; 78: 17-24. (Pubitemid 41373312)
38. Iozzo RV, Moscatello DK, McQuillan DJ, Eichstetter I. Decorin is a biological ligand for the epidermal growth factor receptor. J Biol Chem 1999; 274: 4489-92.
39. Isaka Y, Brees DK, Ikegaya K, Kaneda Y, Imai E, Noble NA, et al. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med 1996; 2: 418-23. (Pubitemid 26191913)
40. Kamizono S, Hanada T, Yasukawa H, Minoguchi S, Kato R, Minoguchi M, et al. The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2. J Biol Chem 2001; 276: 12530-8.
41. Kaneko S, Iwanami A, Nakamura M, Kishino A, Kikuchi K, Shibata S, et al. A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord. Nat Med 2006; 12: 1380-9. (Pubitemid 44924496)
42. Kile BT, Schulman BA, Alexander WS, Nicola NA, Martin HM, Hilton DJ. The SOCS box: a tale of destruction and degradation. Trends Biochem Sci 2002; 27: 235-41. (Pubitemid 34655444)
43. Klingmuller U, Lorenz U, Cantley LC, Neel BG, Lodish HF. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactiva-tion of JAK2 and termination of proliferative signals. Cell 1995; 80: 729-38.
44. Kolb M, Margetts PJ, Galt T, Sime PJ, Xing Z, Schmidt M, et al. Transient transgene expression of decorin in the lung reduces the fibrotic response to bleomycin. Am J Respir Crit Care Med 2001a; 163: 770-7. (Pubitemid 32230842)
45. Kolb M, Margetts PJ, Sime PJ, Gauldie J. Proteoglycans decorin and biglycan differentially modulate TGF-beta-mediated fibrotic responses in the lung. Am J Physiol Lung Cell Mol Physiol 2001b; 280: L1327-34.
46. Kolodkin AL, Levengood DV, Rowe EG, Tai YT, Giger RJ, Ginty DD. Neuropilin is a semaphorin III receptor. Cell 1997; 90: 753-62. (Pubitemid 27357966)
47. Krebs DL, Hilton DJ. SOCS: physiological suppressors of cytokine signaling. J Cell Sci 2000; 113 (Pt 16): 2813-9.
48. Levitzki A, Gazit A. Tyrosine kinase inhibition: an approach to drug development. Science 1995; 267: 1782-8.
49. Lim CP, Phan TT, Lim IJ, Cao X. Stat3 contributes to keloid pathogenesis via promoting collagen production, cell proliferation and migration. Oncogene 2006; 25: 5416-25. (Pubitemid 44330284)
50. Lindholm T, Skold MK, Suneson A, Carlstedt T, Cullheim S, Risling M. Semaphorin and neuropilin expression in motoneurons after intraspinal motoneuron axotomy. Neuroreport 2004; 15: 649-54. (Pubitemid 38457154)
51. Linggi B, Carpenter G. ErbB receptors: new insights on mechanisms and biology. Trends Cell Biol 2006; 16: 649-56. (Pubitemid 44809890)
52. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-8. (Pubitemid 34164012)
53. Logan A, Baird A, Berry M. Decorin attenuates gliotic scar formation in the rat cerebral hemisphere. Exp Neurol 1999; 159: 504-10. (Pubitemid 29485236)
54. Marin O, Yaron A, Bagri A, Tessier-Lavigne M, Rubenstein JL. Sorting of striatal and cortical interneurons regulated by semaphorin-neuropilin interactions. Science 2001; 293: 872-5. (Pubitemid 32743978)
55. Messersmith EK, Leonardo ED, Shatz CJ, Tessier-Lavigne M, Goodman CS, Kolodkin AL. Semaphorin III can function as a selective chemorepellent to pattern sensory projections in the spinal cord. Neuron 1995; 14: 949-59.
56. Minor K, Tang X, Kahrilas G, Archibald SJ, Davies JE, Davies SJ. Decorin promotes robust axon growth on inhibitory CSPGs and myelin via a direct effect on neurons. Neurobiol Dis 2008; 32: 88-95.
57. Mire E, Thomasset N, Jakeman LB, Rougon G. Modulating Sema3A signal with a L1 mimetic peptide is not sufficient to promote motor recovery and axon regeneration after spinal cord injury. Mol Cell Neurosci 2008; 37: 222-35. (Pubitemid 351173845)
58. Montolio M, Messeguer J, Masip I, Guijarro P, Gavin R, Antonio Del RJ, et al. A semaphorin 3A inhibitor blocks axonal chemorepulsion and enhances axon regeneration. Chem Biol 2009; 16: 691-701.
59. Morita A, Yamashita N, Sasaki Y, Uchida Y, Nakajima O, Nakamura F, et al. Regulation of dendritic branching and spine maturation by semaphorin3A-Fyn signaling. J Neurosci 2006; 26: 2971-80.
60. Moscatello DK, Santra M, Mann DM, McQuillan DJ, Wong AJ, Iozzo RV. Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor. J Clin Invest 1998; 101: 406-12. (Pubitemid 28067338)
61. Ni CY, Murphy MP, Golde TE, Carpenter G. Gamma-secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science 2001; 294: 2179-81. (Pubitemid 33150677)
62. Ni CY, Yuan H, Carpenter G. Role of the ErbB-4 carboxyl terminus in gamma-secretase cleavage. J Biol Chem 2003; 278: 4561-5. (Pubitemid 36800952)
63. Niclou SP, Franssen EH, Ehlert EM, Taniguchi M, Verhaagen J. Meningeal cell-derived semaphorin 3A inhibits neurite outgrowth. Mol Cell Neurosci 2003; 24: 902-12. (Pubitemid 38091505)
64. Ogata H, Chinen T, Yoshida T, Kinjyo I, Takaesu G, Shiraishi H, et al. Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta1 production. Oncogene 2006; 25: 2520-30.
65. Ortiz-Munoz G, Lopez-Parra V, Lopez-Franco O, Fernandez-Vizarra P, Mallavia B, Flores C, et al. Suppressors of cytokine signaling abrogate diabetic nephropathy. J Am Soc Nephrol 2010; 21: 763-72.
66. Pasterkamp RJ, Anderson PN, Verhaagen J. Peripheral nerve injury fails to induce growth of lesioned ascending dorsal column axons into spinal cord scar tissue expressing the axon repellent Semaphorin3A. Eur J Neurosci 2001; 13: 457-71. (Pubitemid 32158777)
67. Pasterkamp RJ, Giger RJ. Semaphorin function in neural plasticity and disease. Curr Opin Neurobiol 2009; 19: 263-74.
68. Pasterkamp RJ, Giger RJ, Ruitenberg MJ, Holtmaat AJ, de WJ, De WF, et al. Expression of the gene encoding the chemorepellent semaphorin III is induced in the fibroblast component of neural scar tissue formed following injuries of adult but not neonatal CNS. Mol Cell Neurosci 1999; 13: 143-66. (Pubitemid 29210464)
69. Patel S, Santra M, McQuillan DJ, Iozzo RV, Thomas AP. Decorin activates the epidermal growth factor receptor and elevates cytosolic Ca2+ in A431 carcinoma cells. J Biol Chem 1998; 273: 3121-4. (Pubitemid 28109714)
70. Polleux F, Giger RJ, Ginty DD, Kolodkin AL, Ghosh A. Patterning of cortical efferent projections by semaphorin-neuropilin interactions. Science 1998; 282: 1904-6. (Pubitemid 28555272)
71. Polleux F, Morrow T, Ghosh A. Semaphorin 3A is a chemoattractant for cortical apical dendrites. Nature 2000; 404: 567-73. (Pubitemid 30205047)
72. Puricelli L, Proietti CJ, Labriola L, Salatino M, Balana ME, Aguirre GJ, et al. Heregulin inhibits proliferation via ERKs and phosphatidyl-inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells. Int J Cancer 2002; 100: 642-53. (Pubitemid 34832973)
73. Puschel AW, Adams RH, Betz H. Murine semaphorin D/collapsin is a member of a diverse gene family and creates domains inhibitory for axonal extension. Neuron 1995; 14: 941-8.
74. Rakesh K, Agrawal DK. Controlling cytokine signaling by constitutive inhibitors. Biochem Pharmacol 2005; 70: 649-57. (Pubitemid 41058699)
75. Rewcastle GW, Murray DK, Elliott WL, Fry DW, Howard CT, Nelson JM, et al. Tyrosine kinase inhibitors. 14. Structure-activity relationships for methylamino-substituted derivatives of 4-[(3-bromophenyl)amino]-6-(methylamino)- pyrido[3,4-d]pyrimidine (PD 158780), a potent and specific inhibitor of the tyrosine kinase activity of receptors for the EGF family of growth factors. J Med Chem 1998; 41: 742-51. (Pubitemid 28114883)
76. Rio C, Buxbaum JD, Peschon JJ, Corfas G. Tumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/ HER4. J Biol Chem 2000; 275: 10379-87. (Pubitemid 30202097)
77. Sahay A, Kim CH, Sepkuty JP, Cho E, Huganir RL, Ginty DD, et al. Secreted semaphorins modulate synaptic transmission in the adult hippocampus. J Neurosci 2005; 25: 3613-20.
78. Santra M, Eichstetter I, Iozzo RV. An anti-oncogenic role for decorin. Down-regulation of ErbB2 leads to growth suppression and cytodiffer-entiation of mammary carcinoma cells. J Biol Chem 2000; 275: 35153-61.
79. Sasaki Y, Cheng C, Uchida Y, Nakajima O, Ohshima T, Yagi T, et al. Fyn and Cdk5 mediate semaphorin-3A signaling, which is involved in regulation of dendrite orientation in cerebral cortex. Neuron 2002; 35: 907-20.
80. Schaefer L, Tsalastra W, Babelova A, Baliova M, Minnerup J, Sorokin L, et al. Decorin-mediated regulation of fibrillin-1 in the kidney involves the insulin-like growth factor-I receptor and Mammalian target of rapamycin. Am J Pathol 2007; 170: 301-15. (Pubitemid 47339209)
81. Seidler DG, Goldoni S, Agnew C, Cardi C, Thakur ML, Owens RT, et al. Decorin protein core inhibits in vivo cancer growth and metabolism by hindering epidermal growth factor receptor function and triggering apoptosis via caspase-3 activation. J Biol Chem 2006; 281: 26408-18. (Pubitemid 44401849)
82. Shearman MS, Beher D, Clarke EE, Lewis HD, Harrison T, Hunt P, et al. L-685,458, an aspartyl protease transition state mimic, is a potent inhibitor of amyloid beta-protein precursor gamma-secretase activity. Biochemistry 2000; 39: 8698-704. (Pubitemid 30602778)
83. Shepherd I, Luo Y, Raper JA, Chang S. The distribution of collapsin-1 mRNA in the developing chick nervous system. Dev Biol 1996; 173: 185-99. (Pubitemid 26064611)
84. Shibata N, Kakita A, Takahashi H, Ihara Y, Nobukuni K, Fujimura H, et al. Activation of signal transducer and activator of transcription-3 in the spinal cord of sporadic amyotrophic lateral sclerosis patients. Neurodegener Dis 2009; 6: 118-26.
85. Stichel CC, Kappler J, Junghans U, Koops A, Kresse H, Muller HW. Differential expression of the small chondroitin/dermatan sulfate pro-teoglycans decorin and biglycan after injury of the adult rat brain. Brain Res 1995; 704: 263-74. (Pubitemid 26013092)
86. Su Z, Yuan Y, Cao L, Zhu Y, Gao L, Qiu Y, et al. Triptolide promotes spinal cord repair by inhibiting astrogliosis and inflammation. Glia 2010; 58: 901-15.
87. Takahashi T, Fournier A, Nakamura F, Wang LH, Murakami Y, Kalb RG, et al. Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors. Cell 1999; 99: 59-69. (Pubitemid 29468630)
88. Tamagnone L, Artigiani S, Chen H, He Z, Ming GI, Song H, et al. Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell 1999; 99: 71-80. (Pubitemid 29468631)
89. Tamamaki N, Fujimori K, Nojyo Y, Kaneko T, Takauji R. Evidence that Sema3A and Sema3F regulate the migration of GABAergic neurons in the developing neocortex. J Comp Neurol 2003; 455: 238-48. (Pubitemid 35424260)
90. Tamamaki N, Nakamura K, Kaneko T. Cell migration from the corticos-triatal angle to the basal telencephalon in rat embryos. Neuroreport 2001; 12: 775-80. (Pubitemid 32222716)
91. Thiel KW, Carpenter G. ErbB-4 and TNF-alpha converting enzyme localization to membrane microdomains. Biochem Biophys Res Commun 2006; 350: 629-33. (Pubitemid 44550203)
92. Tran TS, Rubio ME, Clem RL, Johnson D, Case L, Tessier-Lavigne M, et al. Secreted semaphorins control spine distribution and morphogenesis in the postnatal CNS. Nature 2009; 462: 1065-9.
93. Warren CM, Landgraf R. Signaling through ERBB receptors: multiple layers of diversity and control. Cell Signal 2006; 18: 923-33.
94. Williams A, Piaton G, Aigrot MS, Belhadi A, Theaudin M, Petermann F, et al. Semaphorin 3A and 3F: key players in myelin repair in multiple sclerosis? Brain 2007; 130: 2554-65. (Pubitemid 47511713)
95. Williams G, Eickholt BJ, Maison P, Prinjha R, Walsh FS, Doherty P. A complementary peptide approach applied to the design of novel sema-phorin/neuropilin antagonists. J Neurochem 2005; 92: 1180-90. (Pubitemid 40344308)
96. Wormald S, Hilton DJ. Inhibitors of cytokine signal transduction. J Biol Chem 2004; 279: 821-4. (Pubitemid 38082600)
97. Yamauchi K, Osuka K, Takayasu M, Usuda N, Nakazawa A, Nakahara N, et al. Activation of JAK/STAT signalling in neurons following spinal cord injury in mice. J Neurochem 2006; 96: 1060-70.
98. Yamaguchi Y, Mann DM, Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 1990; 346: 281-4.
99. Yamashita N, Morita A, Uchida Y, Nakamura F, Usui H, Ohshima T, et al. Regulation of spine development by semaphorin3A through cyclin-dependent kinase 5 phosphorylation of collapsin response mediator protein 1. J Neurosci 2007; 27: 12546-54. (Pubitemid 350127813)
100. Zafiropoulos A, Tzanakakis GN. Decorin-mediated effects in cancer cell biology. Connect Tissue Res 2008; 49: 244-8.
101. Zhou W, Carpenter G. ErbB-4: a receptor tyrosine kinase. Inflamm Res 2002; 51: 91-101. (Pubitemid 34183633)